BCPCBalchem Corporation
Is the price fair?
The yardsticks disagree: cheap against its own 5-year P/E range (17th percentile) but the cash-flow math implies demanding growth. Treat as fair, not cheap.
Cheap vs its own history: P/E 33.0 vs a 38.9 median over 41 quarters (−15% vs median).
Sector median 18.9× across 51 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What BCPC's price assumes
Balchem Corporation trades at 33.0× earnings against 29.4× for the median Specialty Chemicals name, more expensive than its own group.
Trailing P/E · Specialty Chemicals median 29.4 · 1.12× the median: the market pays up for this one
- Price / sales
- 5.24
Price / sales · today's price, fiscal year to Dec 31, 2025
- Price / book
- 4.32
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 5.17
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 4.32
- EV / EBITtoday's price, fiscal year to Dec 31, 2025
- 25.6
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 5.17
- Basic Materials median P/E203 names
- 20.7
- Specialty Chemicals median P/E43 names
- 29.4
- Market capitalisation
- $5.44B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $180.60 |
| Its own P/E history, median | $197.83 |
| Its own P/E history, upper quartile | $218.03 |
| 52-week range | $139.44 – $183.26 |
| Today | $167.90 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.